BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 29431615)

  • 1. GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling.
    White MA; Tsouko E; Lin C; Rajapakshe K; Spencer JM; Wilkenfeld SR; Vakili SS; Pulliam TL; Awad D; Nikolos F; Katreddy RR; Kaipparettu BA; Sreekumar A; Zhang X; Cheung E; Coarfa C; Frigo DE
    Endocr Relat Cancer; 2018 Apr; 25(4):453-469. PubMed ID: 29431615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleoporin 62 and Ca(2+)/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells.
    Karacosta LG; Kuroski LA; Hofmann WA; Azabdaftari G; Mastri M; Gocher AM; Dai S; Hoste AJ; Edelman AM
    Prostate; 2016 Feb; 76(3):294-306. PubMed ID: 26552607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression.
    Karacosta LG; Foster BA; Azabdaftari G; Feliciano DM; Edelman AM
    J Biol Chem; 2012 Jul; 287(29):24832-43. PubMed ID: 22654108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch.
    Tennakoon JB; Shi Y; Han JJ; Tsouko E; White MA; Burns AR; Zhang A; Xia X; Ilkayeva OR; Xin L; Ittmann MM; Rick FG; Schally AV; Frigo DE
    Oncogene; 2014 Nov; 33(45):5251-61. PubMed ID: 24186207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of CAMKK2 impairs autophagy and castration-resistant prostate cancer via suppression of AMPK-ULK1 signaling.
    Lin C; Blessing AM; Pulliam TL; Shi Y; Wilkenfeld SR; Han JJ; Murray MM; Pham AH; Duong K; Brun SN; Shaw RJ; Ittmann MM; Frigo DE
    Oncogene; 2021 Mar; 40(9):1690-1705. PubMed ID: 33531625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CaM kinase kinase beta-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells.
    Frigo DE; Howe MK; Wittmann BM; Brunner AM; Cushman I; Wang Q; Brown M; Means AR; McDonnell DP
    Cancer Res; 2011 Jan; 71(2):528-37. PubMed ID: 21098087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity.
    Chaurasiya S; Widmann S; Botero C; Lin CY; Gustafsson JÅ; Strom AM
    PLoS One; 2020; 15(5):e0226057. PubMed ID: 32413024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer.
    Shima T; Mizokami A; Miyagi T; Kawai K; Izumi K; Kumaki M; Ofude M; Zhang J; Keller ET; Namiki M
    Prostate; 2012 Dec; 72(16):1789-801. PubMed ID: 22549914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A.
    Desiniotis A; Schäfer G; Klocker H; Eder IE
    Int J Cancer; 2010 Feb; 126(3):775-89. PubMed ID: 19653278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
    MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
    BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
    Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
    Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
    Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer.
    White MA; Lin C; Rajapakshe K; Dong J; Shi Y; Tsouko E; Mukhopadhyay R; Jasso D; Dawood W; Coarfa C; Frigo DE
    Mol Cancer Res; 2017 Aug; 15(8):1017-1028. PubMed ID: 28507054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAMKK2 Promotes Prostate Cancer Independently of AMPK via Increased Lipogenesis.
    Penfold L; Woods A; Muckett P; Nikitin AY; Kent TR; Zhang S; Graham R; Pollard A; Carling D
    Cancer Res; 2018 Dec; 78(24):6747-6761. PubMed ID: 30242113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Androgen Receptor Modulator S42 Suppresses Prostate Cancer Cell Proliferation.
    Kawanami T; Tanaka T; Hamaguchi Y; Nomiyama T; Nawata H; Yanase T
    Endocrinology; 2018 Apr; 159(4):1774-1792. PubMed ID: 29444261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y; Wolff DW; Lin MF; Tu Y
    Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.
    Takayama K; Horie-Inoue K; Suzuki T; Urano T; Ikeda K; Fujimura T; Takahashi S; Homma Y; Ouchi Y; Inoue S
    Mol Endocrinol; 2012 May; 26(5):748-61. PubMed ID: 22456197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
    Mahajan NP; Liu Y; Majumder S; Warren MR; Parker CE; Mohler JL; Earp HS; Whang YE
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8438-43. PubMed ID: 17494760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.